Kim! Hi! It’s your dad!👋 ▪ Khalilah, I’m proud of you for taking a risk for your dream.Everyone’s explanations tend to be so on-point, and the commiseration makes me feel better, too—thanks for the support & good luck studying!                       want to add a message here? just email us!
share email twitter ⋅ join discord whatsapp(2ck)
Free 120  NBME 24  NBME 23  NBME 22  NBME 21  NBME 20  NBME 19  NBME 18  NBME 17  NBME 16  NBME 15  NBME 13 
search for anything NEW!
NBME 16 Answers

nbme16/Block 4/Question#40 (14.0 difficulty score)
A new antiplatelet agent is developed for the ...

Login to comment/vote.

Tutor box

Members from the Leaderboard offering 1-on-1 help: Want to be listed here? Email us!

submitted by aoa05(30),

here are partial clinical manifestations of the right oculomotor nerve palsy:  the right pupil is 6 mm and nonreactive to light, and adduction of the right eye is impaired. The oculomotor nerve exits midbrain through the interpeduncular fossa and goes between the beginning of the posterior cerebral and superior cerebellar arteries. Rapture of an aneurysm in the posterior communicating artery near the beginning of the posterior cerebral artery may compress the oculomotor nerve and affect its function

aoa05  Sorry I meant to post this: Absolute risk reduction or ARR is one of the basic and simplest measures in epidemiology. Another name for this is risk difference It refers to the absolute difference in outcomes between one group (usually the control group) and the group receiving treatment. The percentage tells you how much the risk of something happening decreases if a certain intervention happens. Therefore the stoke rates among women in standard treatment was 0.12 and the stroke rate in women receiving new antiplatelet treatment was 0.04. The ARR is 0.12-0.04 = 0.08 or 8% +10